Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Natera Inc (NTRA)

Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
NTRA
Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings StockStory - Tue Aug 4, 10:22PM CDT

Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings

NTRA : 275.19 (+1.79%)
Natera to Report its Second Quarter Results on August 6, 2026 Business Wire - Thu Jul 30, 7:00AM CDT

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will release results for its second quarter ended June 30, 2026, after the market closes...

NTRA : 275.19 (+1.79%)
BBY
1 Unpopular Stock That Deserves Some Love and 2 We Question StockStory - Sun Jul 26, 11:36PM CDT

1 Unpopular Stock That Deserves Some Love and 2 We Question

NTRA : 275.19 (+1.79%)
BBY : 86.35 (+1.29%)
AMCX : 11.40 (+4.59%)
NTRA
3 Reasons We’re Fans of Natera (NTRA) StockStory - Thu Jul 23, 11:03PM CDT

3 Reasons We’re Fans of Natera (NTRA)

NTRA : 275.19 (+1.79%)
Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study Business Wire - Wed Jul 22, 5:00AM CDT

Signatera outperformed AMERK, the current standard of care for prognosis and recurrence monitoring, across sensitivity, positive and negative predictive value, and lead time to recurrence

NTRA : 275.19 (+1.79%)
NTRA
3 Market-Beating Stocks Worth Your Attention StockStory - Tue Jul 21, 11:33PM CDT

3 Market-Beating Stocks Worth Your Attention

NTRA : 275.19 (+1.79%)
SRCE : 90.82 (+0.34%)
IRTC : 127.13 (+1.98%)
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio Business Wire - Thu Jul 16, 5:35PM CDT

Surveillance coverage significantly strengthened with new LCD across kidney, heart, and lung transplantation, expanding coverage for Prospera testing across critical post-transplant settings

NTRA : 275.19 (+1.79%)
NTRA
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks StockStory - Wed Jul 15, 10:34PM CDT

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

NTRA : 275.19 (+1.79%)
DPZ
1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off StockStory - Thu Jul 9, 11:37PM CDT

1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off

NTRA : 275.19 (+1.79%)
IEX : 237.89 (+2.23%)
DPZ : 367.63 (+0.88%)
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers Business Wire - Thu Jul 9, 5:00AM CDT

Signatera is the first personalized molecular residual disease (MRD) test for solid tumors to receive IVDR certification in the EU

NTRA : 275.19 (+1.79%)

Barchart Exclusives

Anterix Stock Has Nearly Quadrupled Over the Past Year and Could Still Go Higher Barchart - Tue Aug 4, 11:15PM CDT
Anterix (ATEX) has surged 380% over the past year, recently hitting an all-time high of $113. ATEX maintains strong technical momentum with a 100% “Buy” rating from Barchart. Revenue is forecast to grow 220.2% this year and 33.7% next year, supporting continued bullish sentiment. Valuation concerns persist, with Seeking Alpha... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.